As stewards of hunting traditions and New York’s deer population, all hunters should keep their conservation responsibilities ...
Conifex Timber Inc. ('Conifex”, 'we” or 'us”) (TSX: CFF) today reported results for the third quarter ended September 30, ...
The FDA has just restricted the use of ingestible fluoride, and there’s a growing movement to remove fluoride from public ...
The B.C. billionaire’s team has portrayed her as a rags-to-riches business savant who would ‘save Canadian retail.’ But her ...
DARE to PLAY Sildenafil Cream on Track to Launch Before Year End via 503B Pathway, Paving the Way for Near-Term Product RevenuePositive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Contin ...
Following review of the positive interim clinical study results from the Phase 1b/2a trial of BB-301, the U.S. Food and Drug Administration (FDA) granted Fast Track Designation (FTD) to BB-301 for the ...
“During our third quarter of 2025, we continued to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “We ...
Explore the WHO's new guide on water safety, covering 70+ technologies from source protection to household treatment (HWTS). Learn about risk governance, institutional arrangements, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback